A Special Focus on Selexipag - Treatment of Pulmonary Arterial Hypertension

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|23|34|5191-5199

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.23, Iss.34, 2018-01, pp. : 5191-5199

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacologic Treatment of Pulmonary Arterial Hypertension

By  

Current Pharmaceutical Design, Vol. 19, Iss. 22, 2013-07 ,pp. : 3963-3973

Bentham Science Publishers

Access to resources Recommend Favorite

New Insights in the Treatment Strategy for Pulmonary Arterial Hypertension

By Sahara Makoto   Takahashi Toshiyuki   Imai Yasushi   Nakajima Toshiaki   Yao Atsushi   Morita Toshihiro   Hirata Yasunobu   Nagai Ryozo  

Cardiovascular Drugs and Therapy, Vol. 20, Iss. 5, 2006-10 ,pp. : 377-386

Springer Publishing Company

Access to resources Recommend Favorite

Targeted Oral Therapies in the Treatment of Pulmonary Arterial Hypertension

By Safdar Zeenat  

Clinical Drug Investigation, Vol. 30, Iss. 12, 2010-12 ,pp. : 811-826

Adis International

Access to resources Recommend Favorite

Endothelin receptor antagonists for the treatment of pulmonary arterial hypertension

By O'Callaghan Dermot S   Savale Laurent   Yaïïci Azzedine   Natali Delphine   Jaïïs Xavier   Parent Florence   Montani David   Humbert Marc   Simonneau Géérald   Sitbon Olivier  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 10, 2011-07 ,pp. : 1585-1596

Informa Healthcare

Access to resources Recommend Favorite

Iloprost inhalation solution for the treatment of pulmonary arterial hypertension

By Hsu Henry H   Rubin Lewis J  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 11, 2005-09 ,pp. : 1921-1930

Informa Healthcare

Access to resources Recommend Favorite